151 related articles for article (PubMed ID: 31495634)
21. The Effect of Roux-en-Y vs. Omega-Loop Gastric Bypass on Liver, Metabolic Parameters, and Weight Loss.
Kruschitz R; Luger M; Kienbacher C; Trauner M; Klammer C; Schindler K; Langer FB; Prager G; Krebs M; Ludvik B
Obes Surg; 2016 Sep; 26(9):2204-2212. PubMed ID: 27003699
[TBL] [Abstract][Full Text] [Related]
22. In nonalcoholic fatty liver disease, Roux-en-Y gastric bypass improves liver histology while persistent disease is associated with lower improvements in waist circumference and glycemic control.
Schwenger KJP; Fischer SE; Jackson T; Okrainec A; Allard JP
Surg Obes Relat Dis; 2018 Sep; 14(9):1233-1239. PubMed ID: 30049593
[TBL] [Abstract][Full Text] [Related]
23. The Reduction of Visceral Adipose Tissue after Roux-en-Y Gastric Bypass Is more Pronounced in Patients with Impaired Glucose Metabolism.
Favre L; Marino L; Roth A; Acierno J; Hans D; Demartines N; Pitteloud N; Suter M; Collet TH
Obes Surg; 2018 Dec; 28(12):4006-4013. PubMed ID: 30109666
[TBL] [Abstract][Full Text] [Related]
24. Elevated fasting and postprandial C-terminal telopeptide after Roux-en-Y gastric bypass.
Maghsoodi N; Alaghband-Zadeh J; Cross GF; Werling M; Fändriks L; Docherty NG; Olbers T; Dew T; Sherwood RA; Vincent RP; le Roux CW
Ann Clin Biochem; 2017 Jul; 54(4):495-500. PubMed ID: 27555664
[TBL] [Abstract][Full Text] [Related]
25. Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study.
Wickremesekera K; Miller G; Naotunne TD; Knowles G; Stubbs RS
Obes Surg; 2005 Apr; 15(4):474-81. PubMed ID: 15946424
[TBL] [Abstract][Full Text] [Related]
26. Oxidative stress markers in adults 2 years after Roux-en-Y gastric bypass.
Dadalt C; Fagundes RL; Moreira EA; Wilhelm-Filho D; de Freitas MB; Jordão Júnior AA; Biscaro F; Pedrosa RC; Vannucchi H
Eur J Gastroenterol Hepatol; 2013 May; 25(5):580-6. PubMed ID: 23263721
[TBL] [Abstract][Full Text] [Related]
27. Roux-en-Y gastric bypass surgery in youth with severe obesity: 1-year longitudinal changes in spexin.
Kumar S; Hossain MJ; Inge T; Balagopal PB
Surg Obes Relat Dis; 2018 Oct; 14(10):1537-1543. PubMed ID: 30131311
[TBL] [Abstract][Full Text] [Related]
28. Lipid risk profile and weight stability after gastric restrictive operations for morbid obesity.
Brolin RE; Bradley LJ; Wilson AC; Cody RP
J Gastrointest Surg; 2000; 4(5):464-9. PubMed ID: 11077320
[TBL] [Abstract][Full Text] [Related]
29. Can bariatric surgery improve cardiovascular risk factors in the metabolically healthy but morbidly obese patient?
Goday A; Benaiges D; Parri A; Ramón JM; Flores-Le Roux JA; Pedro Botet J;
Surg Obes Relat Dis; 2014; 10(5):871-6. PubMed ID: 25282193
[TBL] [Abstract][Full Text] [Related]
30. Improvement of anthropometric and biochemical, but not of vitamin A, status in adolescents who undergo Roux-en-Y gastric bypass: a 1-year follow up study.
Silva JS; Chaves GV; Stenzel AP; Pereira SE; Saboya CJ; Ramalho A
Surg Obes Relat Dis; 2017 Feb; 13(2):227-233. PubMed ID: 27865810
[TBL] [Abstract][Full Text] [Related]
31. Roux-en-Y-Bariatric Surgery Reduces Markers of Metabolic Syndrome in Morbidly Obese Patients.
Rega-Kaun G; Kaun C; Jaegersberger G; Prager M; Hackl M; Demyanets S; Wojta J; Hohensinner PJ
Obes Surg; 2020 Feb; 30(2):391-400. PubMed ID: 31728904
[TBL] [Abstract][Full Text] [Related]
32. Laparoscopic Roux-En-Y Gastric Bypass Improves Lipid Profile and Decreases Cardiovascular Risk: a 5-Year Longitudinal Cohort Study of 1048 Patients.
Gero D; Favre L; Allemann P; Fournier P; Demartines N; Suter M
Obes Surg; 2018 Mar; 28(3):805-811. PubMed ID: 28971303
[TBL] [Abstract][Full Text] [Related]
33. Effect of laparoscopic Roux
Su Z; Zhu L; Gao X; Li P; Li W; Sun L; Zhu S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Jun; 46(6):609-614. PubMed ID: 34275929
[TBL] [Abstract][Full Text] [Related]
34. Correlation between post over preoperative surrogate insulin resistance indexes' ratios and reversal of metabolic syndrome after Roux-en-Y gastric bypass.
Cazzo E; Callejas-Neto F; Pareja JC; Chaim EA
Obes Surg; 2014 Jun; 24(6):971-3. PubMed ID: 24740593
[TBL] [Abstract][Full Text] [Related]
35. Roux-en-Y gastric bypass decreases pro-inflammatory and thrombotic biomarkers in individuals with extreme obesity.
Netto BD; Bettini SC; Clemente AP; Ferreira JP; Boritza K; Souza Sde F; Von der Heyde ME; Earthman CP; Dâmaso AR
Obes Surg; 2015 Jun; 25(6):1010-8. PubMed ID: 25403776
[TBL] [Abstract][Full Text] [Related]
36. Influence of post-Roux-en-Y gastric bypass weight recidivism on insulin resistance: a 3-year follow-up.
Concon MM; Jimenez LS; Callejas GH; Chaim EA; Cazzo E
Surg Obes Relat Dis; 2019 Nov; 15(11):1912-1916. PubMed ID: 31631000
[TBL] [Abstract][Full Text] [Related]
37. Metabolic improvement of morbid obese patients following Roux-en-Y gastric bypass surgery: A prospective study in Mashhad, Iran.
Fallahi-Shahabad S; Mazidi M; Tavasoli A; Rezaie P; Rohani F; Habibzadeh S; Darchini-Maragheh E; Sefidi ZS; Safarian M; Mobarhan MG; Rajabi MT; Norouzy A; Parizadeh SM; Akhlaghi S; Tavalaie S; Firouzi F; Nematy M
Indian J Gastroenterol; 2016 May; 35(3):195-200. PubMed ID: 27206711
[TBL] [Abstract][Full Text] [Related]
38. Predictors of metabolic syndrome persistence 1 year after laparoscopic Roux-en-Y gastric bypass.
Martini F; Anty R; Schneck AS; Casanova V; Iannelli A; Gugenheim J
Surg Obes Relat Dis; 2015; 11(5):1054-60. PubMed ID: 25868838
[TBL] [Abstract][Full Text] [Related]
39. Long-term weight loss outcomes after banded Roux-en-Y gastric bypass: a prospective 10-year follow-up study.
Magro DO; Ueno M; Coelho-Neto JS; Callejas-Neto F; Pareja JC; Cazzo E
Surg Obes Relat Dis; 2018 Jul; 14(7):910-917. PubMed ID: 29706496
[TBL] [Abstract][Full Text] [Related]
40. Metabolic consequences of the incorporation of a Roux limb in an omega loop (mini) gastric bypass: evaluation by a glucose tolerance test at mid-term follow-up.
Himpens JM; Vilallonga R; Cadière GB; Leman G
Surg Endosc; 2016 Jul; 30(7):2935-45. PubMed ID: 26487198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
